FRI0529 ANALYSIS OF THE EVOLUTION OF CORTICAL AND TRABECULAR BONE COMPARTMENTS IN THE PROXIMAL FEMUR AFTER SPINAL CORD INJURY BY 3D-DXA
Background: Spinal cord injury (SCI) is associated with a marked increase in bone loss and risk of osteoporosis development short-term after injury. 3D-DXA is a new imaging analysis providing volumetric measurements of the cortical and trabecular bone from DXA scans. Objectives: The aim of this study was to assess the evolution of 3D femoral shape, trabecular macrostructure and cortical bone from DXA scans in patients with recent SCI followed over 12 months. Methods: 16 males with recent SCI (<3 months since injury) were included. Clinical assessment, bone mineral density (BMD) measurements and 3D-DXA evaluation at proximal femur (analyzing the integral, trabecular and cortical volumetric BMD [vBMD] and cortical thickness) were performed at baseline and at 6 and 12 months of follow-up. Results: vBMD measured by 3D-DXA significantly decreased at integral, trabecular and cortical compartments at 6 months (-31 Background: Our fracture liaison service (FLS) for outpatients has reported to maintain 73% of the patients on antiresorptive 2 years after the fracture. For hip fracture we are concerned about the low capture rate (27%). Objectives: To analyze the efectiveness of a FLS for inpatients with hip fracture compared with standard care. Methods: Observational study carried out in two hospitals, one with a FLS (Hospital Negrin) and the other one with standard orthogeriatric care (Hospital Candelaria). The reference population >65 y from H.Negrin and H.Candelaria are 63,382 and 63,249 inhabitants respectively. We included patient >65 y with fragility hip fracture ocurred between 1th March 2016 and 31th July 2016. Severe dementia, non-fragility fractures and those patients who died during hospital admittance were excluded. All patients underwent hemogram and biochemistry. The densitometry was not performed on any patient. The only difference between hospitals was a dedicated nurse from the FLS H.Negrin who visited inpatients twice a week, interviewed patients, gave education and applied a treatment protocol to be started by Primary Care. Data recorded were: age, sex, previous fractures and previous treatment for osteoporosis, including calcium, vitamin D, bisphosphonates, denosumab and teriparatide. We also collected the treatment that was included in the discharge report and treatment six month later (checking the electronic prescription). Results: We included 185 patients (105 from Hospital Candelaria and 80 from Hospital Negrin), mean age 82 y (Table) . The percentage of patients receiving a bisphosphonate or equivalent before hospital admittance was similar in both hospitals. However, the percentage after discharge rose by 91% in the hospital with FLS and remain 8% in the hospital with standard care. After six months, 75% of patients from FLS and 15% of patients with standard care had a treatment.
Conclusions:
The implementation of an orthogeriatric FLS lead to an increase in treatment for osteoporosis compared with standard care and similar to our outpatient FLS model. The ideal approach to secondary fracture prevention is a FLS model of care in an integrated health care network, overseen by a nurse coordinator. Background: Androgen deprivation therapy (ADT) is a mainstay therapy for prostate cancer, and a risk factor for bone mineral density (BMD) loss and fractures. Despite this risk, few patients undergo measurement of BMD when initiating ADT. Conceivably, screening for bone loss could lead to identification of patients at risk, and to implementation of bone conserving therapy (BCT), and subsequent decrease in fracture risk. Objectives: To evaluate the utilization of Dual Energy X-ray Absorptiometry (DXA) testing for measurement of BMD in elderly patients with prostate cancer initiating treatment with ADT, and the effects of testing on subsequent fracture risk.
Methods:
We conducted a population-based retrospective cohort study using the Surveillance, Epidemiology, and End Results (SEER) and Texas Cancer Registry (TCR) databases linked to Medicare claims. Medicare is the United States national health insurance program for individuals aged 65 and older. We identified all men over 66 years old with a diagnosis of prostate cancer who received ADT. We identified claims for DXA within 12 months prior, and 12 months after ADT initiation. We assumed that if patients had DXA testing in the year before ADT, this would not be repeated. We then ascertained claims for fractures during follow-up after ADT onset, comparing those who had undergone DXA with those who had not. Statistical analysis included multivariate logistic regression adjusting for demographic and clinical variables. Results: The cohort included 36,739 men with prostate cancer treated with ADT; 48.3% were over 75 years of age and 75% were white. Only 5.2% of the patients underwent DXA within the window of evaluation. Men were more likely to have DXA id the were white vs. African American, and if the lived in census tracts with higher socio-economic status. When comparing the incidence of fractures, 11.3% of those who underwent DXA had a fracture, compared to 19.4% of those who did not undergo DXA (p<0.0001). In the multivariate model an increase in the odds for a fracture was associated with older age, being White, having a prior history of osteoporosis or fracture, were evaluated with DXA.A decrease in the odds for a fracture was associated with having undergone DXA testing (0.70; 95% CI 0.61 -0.80). Conclusions: Very few patients with prostate cancer starting ADT undergo DXA despite being at increased risk of fracture. DXA use was associated with socioeconomic status. Our results show that patients who underwent DXA were significantly less likely to have a fracture. Our findings suggest that DXA should be performed in all patients with prostate cancer initiating ADT. 
